fbpx

PSA welcomes new Tasmanian Health Minister

21 October 2024

 

The Pharmaceutical Society of Australia (PSA) congratulates Jacquie Petrusma MP on her appointment as Tasmania’s next Minister for Health, and thanks outgoing Minister Guy Barnett MP for his service to the portfolio.

 

PSA Tasmania President Mark Kirschbaum FPS welcomed Minister Petrusma to the role.

 

“Minister Petrusma is an experienced, strong leader for Tasmania’s health portfolio,” Mr Kirschbaum said.

 

“Minister Petrusma’s energy and experience as a Registered Nurse will no doubt benefit the sector as we face the nation-wide challenges of an ageing population.

 

“On behalf of pharmacists across Tasmania, I thank Deputy Premier Guy Barnett for his service and leadership in the Tasmanian health portfolio.

 

“His time as Health Minister saw a great deal of progress, utilising the skills and expertise of pharmacists to boost timely, accessible care for Tasmanians.

 

“As we look forward to the next steps of the government’s scope of practice review, PSA looks forward to continuing to work with the Rockliff Government and Minister Petrusma to advocate for the role of pharmacists in our state’s healthcare system.”

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Leading Queensland pharmacists awarded by peak body

20 October 2024

 

The Pharmaceutical Society of Australia (PSA) has presented its 2024 Queensland Excellence Awards in Brisbane last night, recognising five outstanding pharmacists for their commitment to excellence in pharmacy practice.

 

The PSA Queensland branch presented the following awards:

 

  • Queensland Pharmacist of the Year awarded to Associate Professor Esther Lau MPS
  • Queensland Early Career Pharmacist of the Year awarded to James Buckley MPS
  • Queensland Intern Pharmacist of the Year awarded to Antonia Hurd
  • Queensland Lifetime Achievement Award presented to Professor Beverley Glass FPS

 

The annual Professor James Dare Pharmacy Graduate of the Year was also awarded to James Cook University student Shylee-Jade Hadar-Pagliari.

PSA Queensland President Shane MacDonald MPS acknowledged the achievements of the award winners as well as the continued dedication of pharmacists practising throughout the state.

 

“It’s an inspiration to see the amazing work pharmacists are doing in communities across Queensland, and a great privilege to recognise them for their dedication in advancing the profession.

 

“On behalf of the PSA I congratulate the outstanding pharmacists presented with awards and thank them for their commitment to bettering the health of Queenslanders.”

 

Media notes

 

PSA Queensland Pharmacist of the Year Associate Professor Esther Lau MPS has been a transformative force in advancing the pharmacy profession in Queensland. As course coordinator of QUT’s pharmacy program, she played a key role in implementing innovative curricula and leading research for Queensland’s vaccination and UTI pilot programs. One of the first trained pharmacy vaccinators in Australia, Dr. Lau also developed a vaccination training program during COVID-19 to support mass vaccination efforts.

 

Her work in establishing Australia’s first non-medical prescribing course laid the groundwork for expanded pharmacist prescribing pilots. Dr. Lau’s academic achievements include multiple teaching awards, over 50 peer-reviewed publications, and mentoring numerous postgraduate students who now hold leadership roles.

 

Beyond academia, Dr. Lau has been actively involved with the PSA Queensland Branch Committee and has contributed to professional standards and assessments in pharmacy. Her efforts have been pivotal in expanding the role of pharmacists in healthcare, driving practice change, and creating new opportunities for the profession. Dr. Lau’s lasting impact on pharmacy is evident through her dedication, innovation, and commitment to advancing healthcare.

 

 

PSA Queensland Early Career Pharmacist of the Year James Buckley MPS has embraced every opportunity early in his pharmacy career. As managing partner at Live Life Pharmacy in Port Douglas, James was among the first to complete the North Queensland Pharmacist Full Scope of Practice Pilot, providing expanded health services, including additional medicines management and prescribing for a range of common conditions.

 

James’s influence extends beyond his own practice; he has taken on a mentoring role, guiding other pharmacists through the transition to this broader scope of practice. His commitment to knowledge-sharing is evident in his active participation as a speaker at national conferences, where he shares insights on expanded pharmacist roles and the successful implementation of these services. His efforts are not only advancing pharmacy practice in Queensland but are also setting a precedent for broader national adoption of similar models, helping to transform how healthcare is delivered across Australia.

Through his leadership in the North Queensland Pharmacist Full Scope of Practice Pilot, James Buckley is driving significant change in healthcare delivery, demonstrating the critical role that pharmacists can play in improving patient outcomes and strengthening the healthcare workforce.


PSA Queensland Intern Pharmacist of the Year
Antonia Hurd has demonstrated exceptional leadership and commitment during her internship, excelling in patient care, service delivery, and professional engagement. Antonia played a key role in managing essential pharmacy services, including vaccinations, cholesterol and blood glucose testing, and sleep apnoea screening, while also overseeing the dose administration aid service for patients with complex medication needs.

 

A key achievement of Antonia’s internship is her research on the link between chronic pain and mental illness, published as part of the PharMIbridge Randomised Controlled Trial. This work underscores her focus on advancing mental health care within the pharmacy profession. Her involvement in community outreach, including mental health initiatives and educational events, further illustrates her dedication to expanding the role of pharmacists in public health.

 

 

 

PSA Queensland Lifetime Achievement Award recipient Professor Beverley Glass FPS is recognised for her outstanding and sustained contribution to the development of pharmacy education, practice and research, and particularly her role in establishing the James Cook University Pharmacy program which has developed a generation of pharmacists ready for practice in North Queensland.

 

Under her leadership the JCU students have received several awards, including pharmacy student of the year, pharmacy intern of the year and runner up in the national pharmacy student business plan competition. She has invested incredible amounts of time and energy into the future academic workforce also and in supporting the health services and system to solve complex problems in an area of high need. Beverley has completed 50 honours students and 33 PhD and master’s students, many of whom now hold clinical, professional and academic leadership roles in Australia and overseas. Beverley has grown the discipline itself, its academics, and the research profile of the discipline.

 

Prof Glass shares the outcomes of her research with others so they can also learn, having published over 120 peer-reviewed Journal articles in the last 10 years alone and presented her research at both national and international conferences. She is a regular contributor to professional education articles (including Australian Pharmacist) and is part of the Australian Pharmaceutical Formulary compounding expert advisory group. She has given hundreds of research conference presentations and invited national and international keynote, plenary or workshop presentations.

 

Her contributions to the key practice change work within Queensland in UTI and vaccination particularly has seen pharmacists play a pivotal role in access to care in rural and regional Australia and has provided a policy platform for other initiatives, innovations and research work for her team, more recently the first nations children’s ear conditions diagnosis and treatment project and now the North Queensland Full Scope of Practice Pharmacy Pilot. Through her work as a clinician, teacher, researcher, academic and advocate, Professor Glass has been a driving force for rural and remote pharmacy training and practice, forging new roles and pathways for the pharmacists to contribute to healthcare teams. She is a quiet achiever, mentor, support and advocate for pharmacists and pharmacy.

 

 

 

As a final-year pharmacy student at James Cook University, Professor James Dare Pharmacy Graduate of the Year Shylee-Jade Hadar-Pagliari demonstrates exceptional leadership. Shylee’s passion for pharmacy is evident in everything she does, from her dedication to patients and peers, to the profession as a whole.

 

Shylee-Jade consistently goes above and beyond, always striving to ensure the well-being and success of those around her. This level of selflessness speaks to her character and her unwavering commitment to making a positive impact. Her academic achievements are equally impressive. Despite taking on a significant number of professional responsibilities, including as Internal & External Affairs Director for the National Australian Pharmacy Students’ Association (NAPSA), Shylee has managed to maintain a solid academic performance. Her ability to excel in both areas highlights her strong work ethic, determination, and excellent time management skills.

 

In addition to her academic and professional accomplishments, Shylee possesses outstanding leadership qualities. Her natural ability to inspire and guide others is already making a lasting impact on her peers. Shylee personifies the qualities that make a great pharmacist – she is humble, kind, and deeply caring. Her focus is always on the collective success of her patients and colleagues rather than on personal recognition. This integrity and commitment to the greater good reflect her sincerity and devotion to her chosen path.

 

Moreover, Shylee brings a positive and uplifting presence to any environment. Her approachable nature fosters collaboration and camaraderie, making interactions with her both enjoyable and productive. Her contributions to date, along with her potential to make even greater strides in the future, make her a deserving recipient of the 2024 Professor James Dare Pharmacy Graduate of the Year award.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacists back proposal to make interstate prescriptions easier to access in Tasmania

18 October 2024

 

Tasmanian Health Minister Guy Barnett MP has today announced a proposal to amend the Poisons Act 1971 to allow prescriptions issued interstate to be filled by Tasmanian pharmacists.

 

The proposal is welcomed by Pharmaceutical Society of Australia (PSA) Tasmania President Mark Kirschbaum FPS.

 

“The proposed changes to the Poisons Act will have a widespread positive impact, providing greater access to medicines for conditions like ADHD,” Mr Kirschbaum said.

 

“PSA has a long history of advocating for harmonisation of regulations and legislation across the country. We’re glad to see Tasmania take action to ensure medicines are accessible and safe when and where they’re needed.”

 

The Minister also announced that the Tasmanian Department of Health will also undertake a comprehensive review of the Poisons Act. PSA will continue to engage with the Minister’s office and Department to ensure that any legislative changes support the role of pharmacists in the safe and effective use of medicines.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Expanded support for NSW pharmacists participating in Opioid Treatment Program

16 October 2024

 

The Pharmaceutical Society of Australia (PSA) has partnered with New South Wales Health to deliver specialised training and support for pharmacists delivering services under the Opioid Treatment Program (OTP). These supports aim to grow the availability of OTP services across the state.

 

PSA’s expanded support for pharmacists providing OTP services in NSW include a dedicated resource hub, a series of online modules and webinars, and the expansion of the Pharmacist-to-Pharmacist Advice Line to all participating pharmacists.

 

Announcing the partnership, PSA New South Wales President Luke Kelly FPS encouraged pharmacists to consider implementing OTP in their pharmacies.

 

“OTP is an incredibly successful program, rewarding for pharmacists and produces positive outcomes for people accessing treatment. These PSA offerings provide all the support pharmacists need to deliver a high-quality OTP service,” Mr Kelly said.

 

“With the PBS listing effective July 2023, access and affordability of OTP have been significantly improved for people seeking treatment. Pharmacists have a critical role to enhance accessibility.

 

Mr Kelly also encouraged non-participating pharmacists to consider implementing OTP in their pharmacies.

 

“We have areas across NSW that need more community pharmacies delivering OTP to support the need in our communities. I encourage all community pharmacists in NSW to access this training and support, and consider taking on more people on OTP, or providing the service.”

 

In 2022, approximately 55,700 Australians received treatment for opioid dependence on any given day. NSW had the highest rate of people in treatment for opioid dependence, with 30 per 10,000 people, or 24,783 people total. In NSW approximately half of the people accessing OTP services access them from community pharmacists.

 

More information on the new offerings is available below and available at PSA’s NSW OTP hub.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

 

Celebrating Australia’s pharmacy technicians and assistants

15 October 2024

 

Today, the Pharmaceutical Society of Australia (PSA) proudly celebrates Pharmacy Technicians and Assistants Day, recognising Australia’s dedicated pharmacy support staff who work tirelessly to ensure smooth operations and enhance the quality of care we deliver to patients every day – particularly in rural and regional areas.

 

PSA National President Associate Professor Fei Sim FPS emphasised the critical role that pharmacy technicians and assistants play in supporting clinical services.

 

“As the scope of practice for many pharmacists continues to expand, the role of pharmacy assistants and technicians is becoming even more integral to everything we do. From administrative or backend support to direct patient interactions, their contribution to the overall team capacity and efficiency is invaluable,” she said.

 

Pharmacy technicians and assistants are not only involved in the operational aspects of pharmacy practice; they are increasingly taking direct responsibilities to support the role of pharmacists in clinical settings.

 

“The clinical support that technicians and assistants provide allows pharmacists to extend their focus to undertaking clinical roles and practising to their full and top of scope, including in the long term management of diseases, preventive health services, and complex medication therapy,” Associate Professor Sim added. “Their contributions are vital to the seamless integration of clinical services in our pharmacies, ultimately improving health outcomes for our communities.”

 

Associate Professor Sim encouraged all pharmacists to take a moment today to acknowledge the dedication and hard work of their technicians and assistants. “Whether through a formal recognition event or simply a kind word of appreciation, today is a day to show our gratitude for their vital role in the pharmacy profession,” she said.

 

On this Pharmacy Technicians and Assistants Day, the PSA extends its heartfelt thanks to all pharmacy support staff for their tireless efforts and commitment to improving the health and well-being of Australians.

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Updated guidelines for pharmacists providing nicotine dependence support

26 September 2024

 

The Pharmaceutical Society of Australia (PSA) has today released updates to the Guidelines for pharmacists providing smoking cessation support following legislative changes commencing on 1 October 2024.

 

Together, the professional practice guidelines and treatment guidelines set out clear advice on the legal, professional and ethical standards for pharmacists providing nicotine dependence management services, updated to reflect legislative changes to nicotine vaping products.

 

PSA Chief Executive Officer Adjunct Associate Professor Steve Morris said that the release of updated guidelines supports participating pharmacists navigate complex regulatory changes around providing nicotine dependence management services, including nicotine-containing vaping products.

 

“PSA’s core role is to support pharmacists with best-practice guidelines and support across existing and emerging areas of practice as legislation changes,” Adj. A/Prof Morris said.

 

“The updated guidelines released today support pharmacists in navigating legislative changes around nicotine-containing vapes coming into effect from 1 October 2024. They are an essential guide not only for pharmacists who choose to provide nicotine vaping products as a Pharmacist Only medicine, but also those who dispense nicotine-containing vapes on prescription from a doctor or nurse practitioner.

 

“There are significant professional and legal obligations upon pharmacists. These obligations are clarified by updated guidelines, including specific requirements for pharmacist consultation, patient identification, determining clinical appropriateness, documentation such as completing SAS notifications and obtaining informed consent from the consumer.

 

“These guidelines are critical to ensuring patient needs are met while complying with jurisdictional legislative and professional requirements.”

 

PSA invites pharmacists to attend an online webinar this evening (26 September), as well as a series of workshops aimed at further supporting pharmacists to navigate the complex and rapidly changing regulatory environment involving nicotine dependence management.

 

“All pharmacists are strongly encouraged to attend both this week’s upcoming webinar and upcoming local workshops which will allow relevant state and territory legislation to be considered in conjunction with national regulation and these guidelines,” Adj. A/Prof Morris said.

 

Pharmacists can now access the Guidelines for pharmacists providing smoking cessation support. Registrations are essential for upcoming webinars and face-to-face workshops, with limited spaces available. Pharmacists are strongly encouraged to register as soon as possible.

 

The development of the Guidelines for pharmacists providing smoking cessation support has been funded by the Australian Government Department of Health. The work to develop the guidelines included review by experts, stakeholder feedback, and the consensus of organisations and individuals involved.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

NSW Pharmacists welcome permanent expansion of oral contraception access

26 September 2024

 

More women across New South Wales will soon be able to access continued supply of their oral contraceptive from a pharmacist, in a move welcomed by the Pharmaceutical Society of Australia (PSA).

 

From Saturday 28 September 2024, pharmacists not previously selected to participate in the NSW Pharmacy Trial will be able to resupply certain oral contraceptives following completion of additional training. Patient eligibility criteria has also expanded to include patients up to 50 years of age.

 

The announcement comes after the successful trial of services across participating pharmacies in the state, with oral contraceptive services now available permanently.

 

PSA New South Wales President Luke Kelly FPS welcomed the permanent expansion of OCP services.

 

“Pharmacists across New South Wales continue to show that we can do more to support our patients,” Mr Kelly said.

 

“Giving our patients the option to access contraception through skilled community pharmacists is an important step in making reproductive care more accessible to women across the state.

 

“This is one step toward better utilising the skills and expertise of pharmacists to improve health care in New South Wales.

 

I congratulate the Minister on solidifying the role of pharmacists in the continuous supply of oral contraceptives as a permanent part of the New South Wales health care system,” Mr Kelly concluded.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

 

South Australian pharmacists set to boost health care access as scope of practice expands

25 September 2024

 

South Australians will soon be able to access health care for a range of conditions from their local pharmacist, in a move welcomed by the Pharmaceutical Society of Australia (PSA).

 

Pharmacists who undertake postgraduate training will be able to treat skin conditions, ear infections, nausea and vomiting, gastro-oesophageal reflux, musculoskeletal pain and rhinitis, as well as provide wound management services. It is estimated that pharmacists could be delivering services by 2026.

 

The announcement, made on World Pharmacists Day, follows the successful rollout of pharmacy programs allowing South Australian women to access medication for a urinary tract infection and a resupply of their oral contraceptive pill through qualified pharmacists.

 

PSA South Australia and Northern Territory President Dr Manya Angley FPS welcomed the Minister’s announcement to expand pharmacy services in South Australia.

 

“Our profession is continually evolving to better meet the increasingly complex health needs of Australians, our ageing population and overstretched health system,” Dr Angley said.

 

“Pharmacists are successfully supporting patients with treatment for urinary tract infections, resupplying of the oral contraceptive and Mental Health First Aid. These programs are already showing positive outcomes, including a reduction in emergency department visits.”

 

Dr Angley reaffirmed PSA’s commitment to providing high quality education for pharmacists as scope of practice expands in the state.

 

“PSA is an industry-leader in pharmacist education and is looking forward to further supporting South Australian pharmacists to expand their scope of practice.

 

“South Australian health consumers need pharmacists delivering services through the Pharmacy Scope of Practice program. They need all pharmacists doing more to support safe and effective use of medicines and greater access to care when and where they need it.

 

“We’re proud to see South Australia harnessing the potential of pharmacists, allowing us to better support our patients.”

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA Foundation launched, marking World Pharmacist Day

25 September 2024

 

Today, on World Pharmacists Day, the Pharmaceutical Society of Australia (PSA) is proud to officially launch the PSA Foundation, supporting excellence in pharmacy practice by providing funding to support pharmacists’ practice, research, education, and professional development.

 

The PSA Foundation is an Australian Charities and Not-for-profits Commission-registered charity and is deductible gift recipient (DGR) endorsed.

 

The launch closely aligns with the 2025 World Pharmacists Day theme, Pharmacists: Meeting global health needs, reflecting the critical role of pharmacists in improving healthcare access and outcomes worldwide.

 

The PSA Foundation’s Vision and Mission

 

The PSA Foundation’s vision is to optimise pharmacists’ roles in the Australian healthcare system through excellence in pharmacy practice and research.

 

Its mission is to enhance, foster, and promote excellence in pharmacy practice by providing opportunities for research, study, and postgraduate education across all areas of pharmacy practice. Through these efforts, we aim to elevate practice standards and improve public health outcomes for all Australians.

 

Contribution from Pharmaceutical Society of Queensland

 

PSA acknowledges the generous contribution of the Pharmaceutical Society of Queensland (historical society) and the Queensland Pharmacy Research Trust. This donation helps kickstart several initiatives that support the Foundation’s mission to improve public health through innovative pharmacy practice.

 

Associate Professor Fei Sim FPS, Chair of the PSA Foundation Board, emphasised the importance of this donation.

 

“This generous contribution from the Pharmaceutical Society of Queensland and Queensland Pharmacy Research Trust marks an exciting beginning for the PSA Foundation. Thanks to their donation, we are supporting more pharmacists to expand their practice and ultimately deliver better health outcomes for all Australians.

 

“As the Chair of the Foundation, I would like to acknowledge the inaugural Board directors Rhonda White AO FPS, Cathie Reid AM, A/Prof Shane Jackson FPS and Nick Foster, and their significant work in establishing the PSA Foundation.

 

“The establishment of the Foundation unlocks funds from historical trusts and expand them further. This ensures ongoing support for members of the profession, especially during critical periods of practice change as we see now.

 

“Through the PSA Foundation we are able to grow support for the future of pharmacy, starting today.”

 

Mental Health First Aid (MHFA) Training Grants – Applications now open

 

Thanks to the generous donation of the Pharmaceutical Society of Queensland, the PSA Foundation is pleased to announce grant opportunities for Queensland pharmacists to undertake Mental Health First Aid (MHFA) training, supported by the Foundation.

 

Mental Health First Aid training strengthens pharmacists’ capacity to provide critical first aid to members of our communities facing mental health challenges.

 

Queensland pharmacists are invited to submit their Expression of Interest (EOI) to take part. Applications will be assessed, and grants awarded based on the personal and professional experience of applicants, as well as the communities they serve.

 

“This MHFA training will empower pharmacists to play an even greater role in supporting mental health across Queensland, ensuring that patients can access help when and where they need it,” said Associate Professor Sim.

 

“It is also an opportunity to upskill our profession to support our friends and colleagues as our practice is getting more complex and face growing pressures as pharmacists.

 

“This is an exciting first step for the PSA Foundation to support the growing roles of pharmacists. The Foundation Board is already progressing initiatives across other states and territories, and welcomes contact from stakeholders interested in supporting the Foundation’s mission to ensure a strong future for pharmacy and healthcare innovation.”

 

For more information on the PSA Foundation and its upcoming initiatives, and to apply for MFHA grants, visit the PSA Foundation website at www.psa.org.au/psa-foundation.

PSA Foundation media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Empowering pharmacists to meet Australia’s health needs

25 September 2024

Marking World Pharmacists Day today (25 September), Australia’s peak body for pharmacists the Pharmaceutical Society of Australia (PSA) reaffirms the key actions that form its flagship vision Pharmacists in 2030, highlighting the growing role of Australia’s pharmacists in meeting health needs.

 

Pharmacists around Australia and the world are responding to health challenges every day. Whether this be improving access to essential medicines, vaccination services and health advice, or optimising medicine use for safety and efficacy, pharmacists are on the frontlines of Australia’s health care system every day.

 

Last month PSA released Pharmacists in 2030, mapping the direction of the pharmacy profession over the coming years. Pharmacists in 2030 further identifies the key areas for reform in both practice and workforce development necessary to meet the health challenges of the future.

 

Pharmacists in 2030 continues a strong focus on medicine safety and improving access to care and medicines, also building an increased focus on patient equity, sustainability and supports which empower pharmacists to be the best they can be.

 

PSA National President Associate Professor Fei Sim FPS said that the future PSA sees further harnesses the potential of pharmacists.

 

“Australians need the expertise of pharmacists more than ever before,” Associate Professor Sim said. “As medicine use continues to grow and our population ages, Australian health needs are becoming more complex.”

 

“PSA sees pharmacists in all areas of practice doing more to meet these health challenges, and supported to do more for their patients or the communities they serve.

 

“By 2030, we see community pharmacy formally recognised as a preventive and primary health care hub where pharmacists are appropriately funded to practise to full and top of scope and play a greater role in preventive health care, treatment of acute illnesses and management of chronic health conditions – particularly through an increased prescribing role.

 

“While most community pharmacies will remain broad in their health offering to the community, some will become more specialised and focused to meet specific needs.

 

“Many of these changes are already well underway with various scope of practice pilots and changes occurring in every state and territory. These innovations and initiatives have been driven by real patient need and health system demand.

 

“We also see the need for pharmacists wherever medicines are prescribed, dispensed, administered or reviewed. This means playing a bigger role in multidisciplinary health care teams.

 

“Some of these roles will be relevant to community pharmacists, particularly in outreach services, others will see pharmacists embedded in these teams, often being a key conduit to reduce medicine safety risks in liaison with a patient’s community pharmacy.

 

“To the 38,000 pharmacists practising around the country, make sure you take a moment to celebrate your contribution to the health and wellbeing of your community this World Pharmacy Week and particularly today on World Pharmacists Day. On behalf of PSA, thank you for all that you do,” Associate Professor Sim concluded.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au